Bank Of New York Mellon Corp Ocular Therapeutix, Inc Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$2.61 - $4.41 $695,189 - $1.17 Million	266,356 New	266,356 $748,000
Q3 2022 Nov 14, 2022	BUY	$4.09 - $6.5 $88,311 - $140,348	21,592 Added 8.67%	270,610 $1.12 Million
Q2 2022 Aug 15, 2022	SELL	$3.01 - $5.22 $42,206 - $73,194	-14,022 Reduced 5.33%	249,018 $1 Million
Q1 2022 May 11, 2022	BUY	$4.83 - $7.35 $9,094 - $13,840	1,883 Added 0.72%	263,040 $1.3 Million
Q4 2021 Feb 11, 2022	BUY	$6.16 - $12.07 $91,291 - $178,877	14,820 Added 6.02%	261,157 $1.82 Million
Q3 2021 Nov 12, 2021	BUY	$9.7 - $14.34 $269,970 - $399,110	27,832 Added 12.74%	246,337 $2.46 Million
Q2 2021 Aug 11, 2021	SELL	$13.43 - $19.16 $529,303 - $755,133	-39,412 Reduced 15.28%	218,505 $3.1 Million
Q1 2021 May 13, 2021	SELL	$15.82 - $22.11 $1.03 Million - $1.45 Million	-65,394 Reduced 20.23%	257,917 $4.23 Million
Q4 2020 Feb 09, 2021	BUY	$7.91 - $22.95 $1.07 Million - $3.12 Million	135,811 Added 72.43%	323,311 $6.69 Million
Q3 2020 Nov 12, 2020	BUY	$7.36 - $9.87 $138,610 - $185,881	18,833 Added 11.17%	187,500 $1.43 Million
Q2 2020 Aug 12, 2020	BUY	$4.67 - $8.95 $211,714 - $405,748	45,335 Added 36.76%	168,667 $1.4 Million
Q1 2020 May 06, 2020	BUY	$3.95 - $7.4 $14,468 - $27,106	3,663 Added 3.06%	123,332 $610,000
Q4 2019 Feb 14, 2020	BUY	$2.57 - $4.73 $19,010 - $34,987	7,397 Added 6.59%	119,669 $472,000
Q3 2019 Nov 07, 2019	BUY	$3.04 - $5.32 $20,687 - $36,202	6,805 Added 6.45%	112,272 $341,000
Q2 2019 Aug 12, 2019	BUY	$2.46 - $4.52 $7,355 - $13,514	2,990 Added 2.92%	105,467 $464,000
Q1 2019 May 14, 2019	BUY	$3.51 - $4.77 $11,537 - $15,678	3,287 Added 3.31%	102,477 $407,000
Q4 2018 Feb 11, 2019	BUY	$3.87 - $7.11 $18,947 - $34,810	4,896 Added 5.19%	99,190 $395,000
Q2 2018 Aug 06, 2018	BUY	$5.99 - $8.17 $67,543 - $92,124	11,276 Added 13.58%	94,294 $636,000
Q1 2018 May 15, 2018	BUY	$4.66 - $7.08 $63,837 - $96,988	13,699 Added 19.76%	83,018 $541,000
Q4 2017 Feb 09, 2018	BUY	$3.73 - $6.37 $258,559 - $441,562	69,319	69,319 $309,000

Others Institutions Holding OCUL

# of Institutions

173

Shares Held

136M

Call Options Held

150K

Put Options Held

225K

View Full List

About OCULAR THERAPEUTIX, INC

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $617M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

More about OCUL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account